Shannon C King, MA LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 918 Alder Ave, Sumner, WA 98390 Phone: 253-227-3222 Fax: 253-891-1044 |
Mrs. Lillian Ronda Bishop, MED Counselor Medicare: Not Enrolled in Medicare Practice Location: 1818 Main Street, Suite C, Sumner, WA 98390 Phone: 253-863-1997 Fax: 253-863-1997 |
Mark A. Walrath, LMHC, CDP Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 918 Alder Ave, Sumner, WA 98390 Phone: 253-891-2662 Fax: 253-891-1044 |
Mrs. Linda Kay Walrath, CDP Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 918 Alder Ave, Sumner, WA 98390 Phone: 253-891-2662 Fax: 253-891-1044 |
Mrs. Alicia Culp, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1818 Main St Ste C, Sumner, WA 98390 Phone: 253-565-4484 Fax: 253-565-5823 |
Robert Josiah Jensen Counselor Medicare: Not Enrolled in Medicare Practice Location: 15324 Main St E, Sumner, WA 98390 Phone: 253-830-4119 |
Ms. Christine Ellen Christian, MA LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 920 Alder Ave, Suite 203a, Sumner, WA 98390 Phone: 253-370-7970 |
Mr. Gareth Duane Hemminger, M.A., LMFT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 918 Alder Ave, Sumner, WA 98390 Phone: 253-891-2662 |
Yvonne M Bryght, MA, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1006 Fryar Ave Ste B2, Sumner, WA 98390 Phone: 253-826-2923 Fax: 253-826-2916 |
Ms. Nancy A. Mellor, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1818 Main St, Suite C, Sumner, WA 98390 Phone: 253-863-1997 |
Permelia May Foster, CDP Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1325 Bonney Ave Apt 1, Sumner, WA 98390 Phone: 253-252-9622 |
News Archive
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
It has been nearly a century since the term "schizophrenia" was first used to describe what was then considered a hopeless and incurable disorder of thought and emotion. Schizophrenia is still baffling to both scientists and the general public, but it is no longer considered hopeless. Significant advances have been made on several fronts in fathoming and combating this debilitating mental illness-from genetics to neuroscience to the psychosocial aspects of the disorder.
Exposure to loud noise, such as a firecracker or an ear-splitting concert, is the most common preventable cause of hearing loss. Research suggests that 12% or more of the world population is at risk for noise-induced loss of hearing.
Research from the University of Southampton has shown that young adults, who are more outgoing or more emotionally stable, are happier in later life than their more introverted or less emotionally stable peers.
The Quantum Group, Inc. announced that the third version of PWeRTM (Personal Wellness electronic RecordTM), PWeR 3.0, has deployed according to schedule. PWeR is the one patient, one record™ medical record platform that the Company believes is a relevant and real solution to meet current federal healthcare mandates and stimulus programs.
› Verified 5 days ago